Tom Bersot, MD, PhD
Professor
Medicine
School of Medicine

Education & Training

Show all (1) Hide

• Residency School of Medicine University of California, San Francisco

Publications (40)

Top publication keywords:
Practice Guidelines as TopicDyslipidemiasCholesterol, HDLFatty Acids, Omega-3CholesterolCoronary DiseaseLipaseTurkeyHypertriglyceridemiaWaist CircumferenceApolipoproteins EMetabolic SyndromeTriglyceridesHyperlipidemiasLipoproteins, HDL

• Effect of a High-Fructose Weight-Maintaining Diet on Lipogenesis and Liver Fat.
  The Journal of clinical endocrinology and metabolism 2015 Schwarz JM, Noworolski SM, Wen MJ, Dyachenko A, Prior JL, Weinberg ME, Herraiz LA, Tai VW, Bergeron N, Bersot TP, Rao MN, Schambelan M, Mulligan K
• [Official document of the International Society of Atherosclerosis: general recommendations for treatment of dyslipidemia. Executive summary].
  Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis 2013 IAS Panel for Global Recommendations for the Management of Dyslipidemia, Grundy SM, Arai H, Barter P, Bersot TP, Betteridge DJ, Carmena R, Cuevas A, Davidson MH, Genest J, Kesäniemi YA, Sadikot S, …
• Optimal waist:height ratio cut-off point for cardiometabolic risk factors in Turkish adults.
  Public health nutrition 2009 Can AS, Yildiz EA, Samur G, Rakicioglu N, Pekcan G, Ozbayrakçi S, Palaoglu KE, Gönen M, Bersot TP
• Genome-wide linkage and association analyses to identify genes influencing adiponectin levels: the GEMS Study.
  Obesity (Silver Spring, Md.) 2009 Ling H, Waterworth DM, Stirnadel HA, Pollin TI, Barter PJ, Kesäniemi YA, Mahley RW, McPherson R, Waeber G, Bersot TP, Cohen JC, Grundy SM, Mooser VE, Mitchell BD
• Comparison between Turkish Cardiovascular Risk Platform and United States National Cholesterol Education Program Adult Treatment Panel III definitions of the metabolic syndrome in Turkish adults.
  Journal of the cardiometabolic syndrome 2009 Can AS, Ozbayrakçi S, Palaoglu KE, Bersot TP

Show all (35 more) Hide

• Anthropometric indices and their relationship with cardiometabolic risk factors in a sample of Turkish adults.
  Public health nutrition 2008 Can AS, Bersot TP, Gönen M, Pekcan G, Rakicioglu N, Samur G, Yildiz EA
• Analysis of agreement among definitions of metabolic syndrome in nondiabetic Turkish adults: a methodological study.
  BMC public health 2007 Can AS, Bersot TP
• Genetic and phenotypic architecture of metabolic syndrome-associated components in dyslipidemic and normolipidemic subjects: the GEMS Study.
  Atherosclerosis 2007 Stirnadel H, Lin X, Ling H, Song K, Barter P, Kesäniemi YA, Mahley R, McPherson R, Waeber G, Bersot T, Cohen J, Grundy S, Mitchell B, Mooser V, Waterworth D
• Serum insulin and inflammatory markers in overweight individuals with and without dyslipidemia.
  The Journal of clinical endocrinology and metabolism 2007 Barter P, McPherson YR, Song K, Kesäniemi YA, Mahley R, Waeber G, Bersot T, Mooser V, Waterworth D, Grundy SM
• Hypertriglyceridemia: management of atherogenic dyslipidemia.
  The Journal of family practice 2006 Bersot T, Haffner S, Harris WS, Kellick KA, Morris CM
• High density lipoprotein cholesterol in coronary artery patients: is it as low as expected?
  Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology 2006 Mahley RW, Bersot TP
• Modulation of high-density lipoproteins in a population in istanbul, Turkey, with low levels of high-density lipoproteins.
  The American journal of cardiology 2005 Mahley RW, Can S, Ozbayrakçi S, Bersot TP, Tanir S, Palaoglu KE, Pépin GM
• Multiple QTLs influencing triglyceride and HDL and total cholesterol levels identified in families with atherogenic dyslipidemia.
  Journal of lipid research 2005 Yu Y, Wyszynski DF, Waterworth DM, Wilton SD, Barter PJ, Kesäniemi YA, Mahley RW, McPherson R, Waeber G, Bersot TP, Ma Q, Sharma SS, Montgomery DS, Middleton LT, Sundseth SS, Mooser V, Grundy SM, …
• Relation between atherogenic dyslipidemia and the Adult Treatment Program-III definition of metabolic syndrome (Genetic Epidemiology of Metabolic Syndrome Project).
  The American journal of cardiology 2005 Wyszynski DF, Waterworth DM, Barter PJ, Cohen J, Kesäniemi YA, Mahley RW, McPherson R, Waeber G, Bersot TP, Sharma SS, Nolan V, Middleton LT, Sundseth SS, Farrer LA, Mooser V, Grundy SM
• Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol.
  American heart journal 2003 Bersot TP, Pépin GM, Mahley RW
• Antibody phenotyping test for the human apolipoprotein E2 isoform.
  Clinical chemistry 2003 Raffaï RL, McPherson R, Weisgraber KH, Innerarity TL, Rassart E, Bersot TP, Milne RW
• Managing dyslipidemia in Turkey: suggested guidelines for a population characterized by low levels of high density lipoprotein cholesterol.
  Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology 2002 Bersot TP, Palaoglu KE, Mahley RW
• Sources of variability in genetic association studies: insights from the analysis of hepatic lipase (LIPC).
  Human mutation 2002 Shohet RV, Vega GL, Bersot TP, Mahley RW, Grundy SM, Guerra R, Cohen JC
• Plasma lipids in Turkish children: impact of puberty, socioeconomic status, and nutrition on plasma cholesterol and HDL.
  Journal of lipid research 2001 Mahley RW, Arslan P, Pekcan G, Pépin GM, Agaçdiken A, Karaagoglu N, Rakicioglu N, Nursal B, Dayanikli P, Palaoglu KE, Bersot TP
• Low levels of high density lipoproteins in Turks, a population with elevated hepatic lipase. High density lipoprotein characterization and gender-specific effects of apolipoprotein e genotype.
  Journal of lipid research 2000 Mahley RW, Pépin J, Palaoglu KE, Malloy MJ, Kane JP, Bersot TP
• Elevated hepatic lipase activity and low levels of high density lipoprotein in a normotriglyceridemic, nonobese Turkish population.
  Journal of lipid research 1999 Bersot TP, Vega GL, Grundy SM, Palaoglu KE, Atagündüz P, Ozbayrakçi S, Gökdemir O, Mahley RW
• The -514 polymorphism in the hepatic lipase gene (LIPC) does not influence androgen-mediated stimulation of hepatic lipase activity.
  Journal of lipid research 1998 Vega GL, Gao J, Bersot TP, Mahley RW, Verstraete R, Grundy SM, White A, Cohen JC
• A unique haplotype of the apolipoprotein B-100 allele associated with familial defective apolipoprotein B-100 in a Chinese man discovered during a study of the prevalence of this disorder.
  Journal of lipid research 1993 Bersot TP, Russell SJ, Thatcher SR, Pomernacki NK, Mahley RW, Weisgraber KH, Innerarity TL, Fox CS
• Familial defective apolipoprotein B-100: a mutation of apolipoprotein B that causes hypercholesterolemia.
  Journal of lipid research 1990 Innerarity TL, Mahley RW, Weisgraber KH, Bersot TP, Krauss RM, Vega GL, Grundy SM, Friedl W, Davignon J, McCarthy BJ
• Type III hyperlipoproteinemia associated with apolipoprotein E phenotype E3/3. Structure and genetics of an apolipoprotein E3 variant.
  The Journal of clinical investigation 1989 Rall SC, Newhouse YM, Clarke HR, Weisgraber KH, McCarthy BJ, Mahley RW, Bersot TP
• Fat feeding in humans induces lipoproteins of density less than 1.006 that are enriched in apolipoprotein [a] and that cause lipid accumulation in macrophages.
  The Journal of clinical investigation 1986 Bersot TP, Innerarity TL, Pitas RE, Rall SC, Weisgraber KH, Mahley RW
• Type III hyperlipoproteinemia: a focus on lipoprotein receptor-apolipoprotein E2 interactions.
  Advances in experimental medicine and biology 1986 Innerarity TL, Hui DY, Bersot TP, Mahley RW
• Purification and characterization of human lipoprotein lipase and hepatic triglyceride lipase. Reactivity with monoclonal antibodies to hepatic triglyceride lipase.
  The Journal of biological chemistry 1985 Cheng CF, Bensadoun A, Bersot T, Hsu JS, Melford KH
• Receptor binding activity of high-density lipoproteins containing apoprotein E from abetalipoproteinemic and normal neonate plasma.
  Metabolism: clinical and experimental 1984 Innerarity TL, Bersot TP, Arnold KS, Weisgraber KH, Davis PA, Forte TM, Mahley RW
• Identification of a new structural variant of human apolipoprotein E, E2(Lys146 leads to Gln), in a type III hyperlipoproteinemic subject with the E3/2 phenotype.
  The Journal of clinical investigation 1983 Rall SC, Weisgraber KH, Innerarity TL, Bersot TP, Mahley RW, Blum CB
• Cholesteryl ester accumulation in mouse peritoneal macrophages induced by beta-migrating very low density lipoproteins from patients with atypical dysbetalipoproteinemia.
  The Journal of clinical investigation 1983 Bersot TP, Innerarity TL, Mahley RW, Havel RJ
• Atypical familial dysbetalipoproteinemia associated with apolipoprotein phenotype E3/3.
  The Journal of clinical investigation 1983 Havel RJ, Kotite L, Kane JP, Tun P, Bersot T
• Apolipoprotein A-IMilano. Detection of normal A-I in affected subjects and evidence for a cysteine for arginine substitution in the variant A-I.
  The Journal of biological chemistry 1983 Weisgraber KH, Rall SC, Bersot TP, Mahley RW, Franceschini G, Sirtori CR
• A-Imilano apoprotein. Isolation and characterization of a cysteine-containing variant of the A-I apoprotein from human high density lipoproteins.
  The Journal of clinical investigation 1980 Weisgraber KH, Bersot TP, Mahley RW, Franceschini G, Sirtori CR
• Isolation and characterization of an apoprotein from the d less than 1.006 lipoproteins of human and canine lymph homologous with the rat A-IV apoprotein.
  Biochemical and biophysical research communications 1978 Weisgraber KH, Bersot TP, Mahley RW
• Alterations in human high-density lipoproteins, with or without increased plasma-cholesterol, induced by diets high in cholesterol.
  Lancet (London, England) 1978 Mahley RW, Innerarity TL, Bersot TP, Lipson A, Margolis S
• Apoprotein (E--A-II) complex of human plasma lipoproteins. II. Receptor binding activity of a high density lipoprotein subfraction modulated by the apo(E--A-II) complex.
  The Journal of biological chemistry 1978 Innerarity TL, Mahley RW, Weisgraber KH, Bersot TP
• Interaction of swine lipoproteins with the low density lipoprotein receptor in human fibroblasts.
  The Journal of biological chemistry 1976 Bersot TP, Mahley RW, Brown MS, Goldstein JL
• Characterization of the rat apolipoproteins. I. The low molecular weight proteins of rat plasma high density lipoproteins.
  The Journal of biological chemistry 1974 Herbert PN, Windmueller HG, Bersot TP, Shulman RS
• Identity of very low density lipoprotein apoproteins of plasma and liver Golgi apparatus.
  Science (New York, N.Y.) 1970 Mahley RW, Bersot TP, LeQuire VS, Levy RI, Windmueller HG, Brown WV